The 9 most recent market catalysts affecting $IQV, each scored for sentiment and estimated stock impact. Sourced from SEC EDGAR filings and financial news, analysed automatically as they are published.
Aug 4, 2026
Corporate Catalyst
Bullish
Impact 75
IQVIA And Medera Announce Strategic Collaboration To Accelerate Cardiac Gene Therapy Development And Human-Based Drug Discovery Platforms
This strategic collaboration is a positive catalyst for both IQVIA and Medera, as it leverages their respective strengths to tackle complex cardiac gene therapy development. IQVIA …
Jul 29, 2026
Corporate Catalyst
Bullish
Impact 65
JP Morgan Maintains Overweight on IQVIA Holdings, Raises Price Target to $285
JP Morgan analyst Casey Woodring has maintained an 'Overweight' rating on IQVIA Holdings (IQV) and raised the price target from $225 to $285. This is a significant upgrade in the p…
Jul 29, 2026
Corporate Catalyst
Bullish
Impact 65
Stifel Maintains Buy on IQVIA Holdings, Raises Price Target to $276
Stifel analyst Shlomo Rosenbaum maintained a 'Buy' rating on IQVIA Holdings and significantly raised the price target from $220 to $276. This action signals increased confidence in…
Jul 29, 2026
Corporate Catalyst
Bullish
Impact 55
RBC Capital Maintains Outperform on IQVIA Holdings, Raises Price Target to $247
RBC Capital's analyst Ryan Halsted has maintained an 'Outperform' rating on IQVIA Holdings (IQV) and raised the price target from $221 to $247. This action signals increased confid…
Jul 29, 2026
Corporate Catalyst
Bullish
Impact 65
BMO Capital Maintains Outperform on IQVIA Holdings, Raises Price Target to $270
BMO Capital analyst Sean Dodge maintained an 'Outperform' rating on IQVIA Holdings and raised the price target from $210 to $270. This is a significant upward revision, indicating …
Jul 29, 2026
Corporate Catalyst
Bullish
Impact 65
Baird Maintains Outperform on IQVIA Holdings, Raises Price Target to $287
Baird analyst Eric Coldwell maintained an 'Outperform' rating on IQVIA Holdings and raised the price target from $252 to $287. This action signals a strong vote of confidence from …
Jul 28, 2026
Corporate Catalyst
Bullish
Impact 85
IQVIA Holdings shares are trading higher after the company reported better-than-expected Q2 financial results and raised its FY26 guidance.
IQVIA's strong earnings report and optimistic future guidance are a significant positive catalyst for the company, reflecting healthy underlying demand in the pharmaceutical and he…
Jul 28, 2026
Corporate Catalyst
Bullish
Impact 75
IQVIA Hldgs Q2 Adj. EPS $3.15 Beats $3.03 Estimate, Sales $4.368B Beat $4.301B Estimate
IQVIA Holdings announced its Q2 earnings, reporting adjusted EPS of $3.15, significantly beating the $3.03 consensus estimate, and sales of $4.368 billion, surpassing the $4.301 bi…
Jul 13, 2026
Corporate Catalyst
Bullish
Impact 55
Mizuho Maintains Outperform on IQVIA Holdings, Raises Price Target to $230
Mizuho analyst Ann Hynes maintained an 'Outperform' rating on IQVIA Holdings and raised the price target from $215 to $230. This action signals continued confidence in IQVIA's perf…
Not financial advice. AI-generated analysis for informational purposes only. Tradow AI LLC is not a registered investment adviser.